Novellus' Series C Round

Novellus raised a round of funding on April 30, 2018.

Novellus is a precision oncology company that has developed a live-cell based assay to monitor the activity of signaling pathways. Using this platform, Novellus' solution helps biopharma companies ide…

Articles about Novellus' Series C Round: